Discovery could guide immunotherapy for lung cancer

Read more

Innocrin Pharmaceuticals Granted SME Status Designation by the EMA

Read more

Nanotherapeutics appoints Peter H. Khoury as President and CEO

Read more

BlackThorn receives $8 Million to advance KOR Antagonist Program

Read more

NanoSphere Health Sciences Signs Binding Merger Agreement for 100% Acquisition by Corazon Gold Corp.

Read more

Navidea Enters Exclusive License and Distribution Agreement For India with Sayre Therapeutics

Read more

FDA Accepts Rigel’s New Drug Application for TAVALISSE

Read more

Lannett Announces Approval For Amantadine Hydrochloride Capsules USP, 100 mg

Read more

Boehringer presents phase III results of adalimumab biosimilar candidate to HUMIRA

Read more

Johnson & Johnson Announces Completion of Acquisition of Actelion

Read more